
zzso growth factor zzso zzso zzso zzso zzso are used widely to treat zzso zzso cancer zzso patients, but it is now clear that patients harboring zzso zzso are resistant to zzso zzso such as zzso zzso and zzso zzso For this reason, current recommendations for patient care involve diagnosing the zzso zzso status of patients prior to zzso zzso zzso In this study, we investigated the ability of two zzso zzso currently in clinical trials, zzso and zzso to address the challenge posed by the resistance of zzso zzso zzso zzso to zzso zzso zzso and zzso were tested in various zzso zzso and tumor zzso studies, focusing on zzso human zzso tumor cell lines that expressed only zzso or zzso zzso zzso or zzso The zzso zzso zzso inhibited the zzso zzso and proliferation of zzso cells in zzso and in zzso but it did not inhibit proliferation of zzso cells in either zzso In contrast, zzso and zzso effectively inhibited the growth of zzso cells in zzso and in zzso by specific zzso of the key zzso downstream target zzso zzso zzso of zzso by zzso or zzso also suppressed zzso zzso cancer cells attributed to zzso zzso both in zzso and in zzso Our findings offer zzso for the use of zzso zzso as an effective therapy in zzso zzso zzso 

